Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

With state-of-the-art facilities and internationally renowned researchers, we are pioneering technologies to improve the diagnosis and monitoring of cancer, and to guide new forms of precision ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial. Researchers found that RP2 – a modified version of the herpes ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

Professor Janet Shipley is investigating ways to improve the treatment of patients with sarcomas that have a poor outcome. Group: Sarcoma Molecular Pathology 0000-0001-6748-8678 Originally from ...